Phase II Trial of concurrent administration of intravesical BCG \& Interferon in the treatment and prevention of recurrence of superficial transitional carcinoma of the urinary bladder.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Chemotherapy
Efficacy
Time frame: overall
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.